-
1
-
-
0034284970
-
Bone resorption by osteoclasts
-
Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508
-
(2000)
Science
, vol.289
, pp. 1504-1508
-
-
Teitelbaum, S.L.1
-
2
-
-
0037673945
-
Osteoclast differentiation and activation
-
Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342
-
(2003)
Nature
, vol.423
, pp. 337-342
-
-
Boyle, W.J.1
Simonet, W.S.2
Lacey, D.L.3
-
3
-
-
30644469500
-
RANKL-RANK signaling in osteoclastogenesis and bone disease
-
Wada, T., Nakashima, T., Hiroshi, N., and Penninger, J. M. (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17-25
-
(2006)
Trends Mol. Med.
, vol.12
, pp. 17-25
-
-
Wada, T.1
Nakashima, T.2
Hiroshi, N.3
Penninger, J.M.4
-
4
-
-
0043267732
-
Genetic regulation of osteoclast development and function
-
Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649
-
(2003)
Nat. Rev. Genet.
, vol.4
, pp. 638-649
-
-
Teitelbaum, S.L.1
Ross, F.P.2
-
5
-
-
33846031926
-
The molecular understanding of osteoclast differentiation
-
Asagiri, M., and Takayanagi, H. (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264
-
(2007)
Bone
, vol.40
, pp. 251-264
-
-
Asagiri, M.1
Takayanagi, H.2
-
6
-
-
33744748571
-
M-CSF, c-Fms, and signaling in osteoclasts and their precursors
-
Ross, F. P. (2006) M-CSF, c-Fms, and signaling in osteoclasts and their precursors. Ann. N. Y. Acad. Sci. 1068, 110-116
-
(2006)
Ann. N. Y. Acad. Sci.
, vol.1068
, pp. 110-116
-
-
Ross, F.P.1
-
7
-
-
18744366041
-
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
-
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T., and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901
-
(2002)
Dev. Cell
, vol.3
, pp. 889-901
-
-
Takayanagi, H.1
Kim, S.2
Koga, T.3
Nishina, H.4
Isshiki, M.5
Yoshida, H.6
Saiura, A.7
Isobe, M.8
Yokochi, T.9
Inoue, J.10
Wagner, E.F.11
Mak, T.W.12
Kodama, T.13
Taniguchi, T.14
-
8
-
-
70450237634
-
Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly
-
Yu, M., Moreno, J. L., Stains, J. P., and Keegan, A. D. (2009) Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly. J. Biol. Chem. 284, 32968-32979
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 32968-32979
-
-
Yu, M.1
Moreno, J.L.2
Stains, J.P.3
Keegan, A.D.4
-
9
-
-
68949163761
-
Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand
-
Balkan, W., Martinez, A. F., Fernandez, I., Rodriguez, M. A., Pang, M., and Troen, B. R. (2009) Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Gene 446, 90-98
-
(2009)
Gene
, vol.446
, pp. 90-98
-
-
Balkan, W.1
Martinez, A.F.2
Fernandez, I.3
Rodriguez, M.A.4
Pang, M.5
Troen, B.R.6
-
10
-
-
33845654949
-
RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation
-
Sundaram, K., Nishimura, R., Senn, J., Youssef, R. F., London, S. D., and Reddy, S. V. (2007) RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res. 313, 168-178
-
(2007)
Exp. Cell Res.
, vol.313
, pp. 168-178
-
-
Sundaram, K.1
Nishimura, R.2
Senn, J.3
Youssef, R.F.4
London, S.D.5
Reddy, S.V.6
-
11
-
-
38049078785
-
NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)
-
Kim, K., Lee, S.-H., Ha Kim, J., Choi, Y., and Kim, N. (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22, 176-185
-
(2008)
Mol. Endocrinol.
, vol.22
, pp. 176-185
-
-
Kim, K.1
Lee, S.-H.2
Ha Kim, J.3
Choi, Y.4
Kim, N.5
-
12
-
-
23744459835
-
DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
-
Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., and Suda, T. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345-351
-
(2005)
J. Exp. Med.
, vol.202
, pp. 345-351
-
-
Yagi, M.1
Miyamoto, T.2
Sawatani, Y.3
Iwamoto, K.4
Hosogane, N.5
Fujita, N.6
Morita, K.7
Ninomiya, K.8
Suzuki, T.9
Miyamoto, K.10
Oike, Y.11
Takeya, M.12
Toyama, Y.13
Suda, T.14
-
13
-
-
79956039791
-
SH2 domain-containing protein-tyrosine phosphatases
-
Dennis, S. A., ed., Elsevier, Inc., New York
-
Neel, B. G., Chan, G., Dhanji, S. (2009) SH2 Domain-Containing Protein-Tyrosine Phosphatases. In Handbook of Cell Signaling (Dennis, S. A., ed.), pp. 771-809, Elsevier, Inc., New York
-
(2009)
Handbook of Cell Signaling
, pp. 771-809
-
-
Neel, B.G.1
Chan, G.2
Dhanji, S.3
-
14
-
-
77954638588
-
The tyrosine phosphatase Shp2 in development and cancer
-
Grossmann, K. S., Rosário, M., Birchmeier, C., and Birchmeier, W. (2010) The tyrosine phosphatase Shp2 in development and cancer. Adv. Cancer Res. 106, 53-89
-
(2010)
Adv. Cancer Res.
, vol.106
, pp. 53-89
-
-
Grossmann, K.S.1
Rosário, M.2
Birchmeier, C.3
Birchmeier, W.4
-
15
-
-
33749611445
-
Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells
-
Lee, A. W., and States, D. J. (2006) Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells. Cell Death Differ. 13, 1900-1914
-
(2006)
Cell Death Differ.
, vol.13
, pp. 1900-1914
-
-
Lee, A.W.1
States, D.J.2
-
16
-
-
17644393474
-
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis
-
Wada, T., Nakashima, T., Oliveira-dos-Santos, A. J., Gasser, J., Hara, H., Schett, G., and Penninger, J. M. (2005) The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat. Med. 11, 394-399
-
(2005)
Nat. Med.
, vol.11
, pp. 394-399
-
-
Wada, T.1
Nakashima, T.2
Oliveira-Dos-Santos, A.J.3
Gasser, J.4
Hara, H.5
Schett, G.6
Penninger, J.M.7
-
17
-
-
4043056497
-
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
-
Araki, T., Mohi, M. G., Ismat, F. A., Bronson, R. T., Williams, I. R., Kutok, J. L., Yang, W., Pao, L. I., Gilliland, D. G., Epstein, J. A., and Neel, B. G. (2004) Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 10, 849-857
-
(2004)
Nat. Med.
, vol.10
, pp. 849-857
-
-
Araki, T.1
Mohi, M.G.2
Ismat, F.A.3
Bronson, R.T.4
Williams, I.R.5
Kutok, J.L.6
Yang, W.7
Pao, L.I.8
Gilliland, D.G.9
Epstein, J.A.10
Neel, B.G.11
-
18
-
-
33749577870
-
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
-
Fornaro, M., Burch, P. M., Yang, W., Zhang, L., Hamilton, C. E., Kim, J. H., Neel, B. G., and Bennett, A. M. (2006) SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth. J. Cell Biol. 175, 87-97
-
(2006)
J. Cell Biol.
, vol.175
, pp. 87-97
-
-
Fornaro, M.1
Burch, P.M.2
Yang, W.3
Zhang, L.4
Hamilton, C.E.5
Kim, J.H.6
Neel, B.G.7
Bennett, A.M.8
-
19
-
-
33644547703
-
An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival
-
Yang, W., Klaman, L. D., Chen, B., Araki, T., Harada, H., Thomas, S. M., George, E. L., and Neel, B. G. (2006) An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317-327
-
(2006)
Dev. Cell
, vol.10
, pp. 317-327
-
-
Yang, W.1
Klaman, L.D.2
Chen, B.3
Araki, T.4
Harada, H.5
Thomas, S.M.6
George, E.L.7
Neel, B.G.8
-
20
-
-
0030921502
-
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
-
Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G. S., and Pawson, T. (1997) Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352-2364
-
(1997)
EMBO J.
, vol.16
, pp. 2352-2364
-
-
Saxton, T.M.1
Henkemeyer, M.2
Gasca, S.3
Shen, R.4
Rossi, D.J.5
Shalaby, F.6
Feng, G.S.7
Pawson, T.8
-
21
-
-
79952319106
-
Development of severe skeletal defects in induced SHP-2-deficient adult mice: A model of skeletal malformation in humans with SHP-2 mutations
-
Bauler, T. J., Kamiya, N., Lapinski, P. E., Langewisch, E., Mishina, Y., Wilkinson, J. E., Feng, G.-S., and King, P. D. (2011) Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations. Dis. Model. Mech. 4, 228-239
-
(2011)
Dis. Model. Mech.
, vol.4
, pp. 228-239
-
-
Bauler, T.J.1
Kamiya, N.2
Lapinski, P.E.3
Langewisch, E.4
Mishina, Y.5
Wilkinson, J.E.6
Feng, G.-S.7
King, P.D.8
-
22
-
-
79955986600
-
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells
-
Chan, G., Cheung, L. S., Yang, W., Milyavsky, M., Sanders, A. D., Gu, S., Hong, W. X., Liu, A. X., Wang, X., Barbara, M., Sharma, T., Gavin, J., Kutok, J. L., Iscove, N. N., Shannon, K. M., Dick, J. E., Neel, B. G., and Braun, B. S. (2011) Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood 117, 4253-4261
-
(2011)
Blood
, vol.117
, pp. 4253-4261
-
-
Chan, G.1
Cheung, L.S.2
Yang, W.3
Milyavsky, M.4
Sanders, A.D.5
Gu, S.6
Hong, W.X.7
Liu, A.X.8
Wang, X.9
Barbara, M.10
Sharma, T.11
Gavin, J.12
Kutok, J.L.13
Iscove, N.N.14
Shannon, K.M.15
Dick, J.E.16
Neel, B.G.17
Braun, B.S.18
-
23
-
-
18344385476
-
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
-
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., Van Der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., Kalidas, K., Patton, M. A., Kucherlapati, R. S., and Gelb, B. D. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465-468
-
(2001)
Nat. Genet.
, vol.29
, pp. 465-468
-
-
Tartaglia, M.1
Mehler, E.L.2
Goldberg, R.3
Zampino, G.4
Brunner, H.G.5
Kremer, H.6
Van Der Burgt, I.7
Crosby, A.H.8
Ion, A.9
Jeffery, S.10
Kalidas, K.11
Patton, M.A.12
Kucherlapati, R.S.13
Gelb, B.D.14
-
24
-
-
33947147117
-
Noonan syndrome and related disorders: Alterations in growth and puberty
-
Noonan, J. A. (2006) Noonan syndrome and related disorders: alterations in growth and puberty. Rev. Endocr. Metab. Disord. 7, 251-255
-
(2006)
Rev. Endocr. Metab. Disord.
, vol.7
, pp. 251-255
-
-
Noonan, J.A.1
-
25
-
-
63849313577
-
Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis
-
Chan, G., Kalaitzidis, D., Usenko, T., Kutok, J. L., Yang, W., Mohi, M. G., and Neel, B. G. (2009) Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis. Blood 113, 4414-4424
-
(2009)
Blood
, vol.113
, pp. 4414-4424
-
-
Chan, G.1
Kalaitzidis, D.2
Usenko, T.3
Kutok, J.L.4
Yang, W.5
Mohi, M.G.6
Neel, B.G.7
-
26
-
-
84881119110
-
Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling
-
Yang, W., Wang, J., Moore, D. C., Liang, H., Dooner, M., Wu, Q., Terek, R., Chen, Q., Ehrlich, M. G., Quesenberry, P. J., and Neel, B. G. (2013) Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499, 491-495
-
(2013)
Nature
, vol.499
, pp. 491-495
-
-
Yang, W.1
Wang, J.2
Moore, D.C.3
Liang, H.4
Dooner, M.5
Wu, Q.6
Terek, R.7
Chen, Q.8
Ehrlich, M.G.9
Quesenberry, P.J.10
Neel, B.G.11
-
27
-
-
0033177995
-
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
-
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., and Förster, I. (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277
-
(1999)
Transgenic Res.
, vol.8
, pp. 265-277
-
-
Clausen, B.E.1
Burkhardt, C.2
Reith, W.3
Renkawitz, R.4
Förster, I.5
-
28
-
-
34548274444
-
Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts
-
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823
-
(2007)
Cell
, vol.130
, pp. 811-823
-
-
Nakamura, T.1
Imai, Y.2
Matsumoto, T.3
Sato, S.4
Takeuchi, K.5
Igarashi, K.6
Harada, Y.7
Azuma, Y.8
Krust, A.9
Yamamoto, Y.10
Nishina, H.11
Takeda, S.12
Takayanagi, H.13
Metzger, D.14
Kanno, J.15
Takaoka, K.16
Martin, T.J.17
Chambon, P.18
Kato, S.19
-
29
-
-
33746217416
-
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor
-
Chen, L., Sung, S. S., Yip, M. L., Lawrence, H. R., Ren, Y., Guida, W. C., Sebti, S. M., Lawrence, N. J., and Wu, J. (2006) Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70, 562-570
-
(2006)
Mol. Pharmacol.
, vol.70
, pp. 562-570
-
-
Chen, L.1
Sung, S.S.2
Yip, M.L.3
Lawrence, H.R.4
Ren, Y.5
Guida, W.C.6
Sebti, S.M.7
Lawrence, N.J.8
Wu, J.9
-
30
-
-
84934442675
-
Determination of bone's mechanical matrix properties by nanoindentation
-
Ozcivici, E., Ferreri, S., Qin, Y. X., and Judex, S. (2008) Determination of bone's mechanical matrix properties by nanoindentation. Methods Mol. Biol. 455, 323-334
-
(2008)
Methods Mol. Biol.
, vol.455
, pp. 323-334
-
-
Ozcivici, E.1
Ferreri, S.2
Qin, Y.X.3
Judex, S.4
-
31
-
-
0027473329
-
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors
-
Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., and Suda, T. (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91, 257-263
-
(1993)
J. Clin. Invest.
, vol.91
, pp. 257-263
-
-
Tanaka, S.1
Takahashi, N.2
Udagawa, N.3
Tamura, T.4
Akatsu, T.5
Stanley, E.R.6
Kurokawa, T.7
Suda, T.8
-
32
-
-
7444232069
-
Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members
-
Xu, D., Shi, Z., McDonald, J., Pan, G., Cao, X., Yu, X., and Feng, X. (2004) Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. Biochem. J. 383, 219-225
-
(2004)
Biochem. J.
, vol.383
, pp. 219-225
-
-
Xu, D.1
Shi, Z.2
McDonald, J.3
Pan, G.4
Cao, X.5
Yu, X.6
Feng, X.7
-
33
-
-
11144222546
-
Osteopetrosis
-
Tolar, J., Teitelbaum, S. L., and Orchard, P. J. (2004) Osteopetrosis. N. Engl. J. Med. 351, 2839-2849
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 2839-2849
-
-
Tolar, J.1
Teitelbaum, S.L.2
Orchard, P.J.3
-
34
-
-
2942731511
-
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
-
Matsuo, K., Galson, D. L., Zhao, C., Peng, L., Laplace, C., Wang, K. Z. Q., Bachler, M. A., Amano, H., Aburatani, H., Ishikawa, H., and Wagner, E. F. (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279, 26475-26480
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 26475-26480
-
-
Matsuo, K.1
Galson, D.L.2
Zhao, C.3
Peng, L.4
Laplace, C.5
Wang, K.Z.Q.6
Bachler, M.A.7
Amano, H.8
Aburatani, H.9
Ishikawa, H.10
Wagner, E.F.11
-
35
-
-
0032982796
-
Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density
-
Umeda, S., Beamer, W. G., Takagi, K., Naito, M., Hayashi, S., Yonemitsu, H., Yi, T., and Shultz, L. D. (1999) Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am. J. Pathol. 155, 223-233
-
(1999)
Am. J. Pathol.
, vol.155
, pp. 223-233
-
-
Umeda, S.1
Beamer, W.G.2
Takagi, K.3
Naito, M.4
Hayashi, S.5
Yonemitsu, H.6
Yi, T.7
Shultz, L.D.8
-
36
-
-
0032816807
-
The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in me (v)/me (v) mutant mice
-
Aoki, K., Didomenico, E., Sims, N. A., Mukhopadhyay, K., Neff, L., Houghton, A., Amling, M., Levy, J. B., Horne, W. C., and Baron, R. (1999) The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me (v)/me (v) mutant mice. Bone 25, 261-267
-
(1999)
Bone
, vol.25
, pp. 261-267
-
-
Aoki, K.1
Didomenico, E.2
Sims, N.A.3
Mukhopadhyay, K.4
Neff, L.5
Houghton, A.6
Amling, M.7
Levy, J.B.8
Horne, W.C.9
Baron, R.10
-
37
-
-
0033816981
-
Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors
-
Lee, A. W., and States, D. J. (2000) Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol. Cell. Biol. 20, 6779-6798
-
(2000)
Mol. Cell. Biol.
, vol.20
, pp. 6779-6798
-
-
Lee, A.W.1
States, D.J.2
-
38
-
-
33750330963
-
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway
-
Huang, H., Chang, E.-J., Ryu, J., Lee, Z. H., Lee, Y., and Kim, H.-H. (2006) Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem. Biophys. Res. Commun. 351, 99-105
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.351
, pp. 99-105
-
-
Huang, H.1
Chang, E.-J.2
Ryu, J.3
Lee, Z.H.4
Lee, Y.5
Kim, H.-H.6
-
39
-
-
47249151777
-
Osteoblasts induce Ca2+ oscillationindependent NFATc1 activation during osteoclastogenesis
-
Kuroda, Y., Hisatsune, C., Nakamura, T., Matsuo, K., and Mikoshiba, K. (2008) Osteoblasts induce Ca2+ oscillationindependent NFATc1 activation during osteoclastogenesis. Proc. Natl. Acad. Sci. USA 105, 8643-8648
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 8643-8648
-
-
Kuroda, Y.1
Hisatsune, C.2
Nakamura, T.3
Matsuo, K.4
Mikoshiba, K.5
-
40
-
-
78349249359
-
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research
-
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D., Einhorn, T. A., Genant, H. K., Geusens, P., Klaushofer, K., Koval, K., Lane, J. M., McKiernan, F., McKinney, R., Ng, A., Nieves, J., O'Keefe, R., Papapoulos, S., Sen, H. T., Van Der Meulen, M. C. H., Weinstein, R. S., and Whyte, M. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 25, 2267-2294
-
(2010)
J. Bone Miner. Res.
, vol.25
, pp. 2267-2294
-
-
Shane, E.1
Burr, D.2
Ebeling, P.R.3
Abrahamsen, B.4
Adler, R.A.5
Brown, T.D.6
Cheung, A.M.7
Cosman, F.8
Curtis, J.R.9
Dell, R.10
Dempster, D.11
Einhorn, T.A.12
Genant, H.K.13
Geusens, P.14
Klaushofer, K.15
Koval, K.16
Lane, J.M.17
McKiernan, F.18
McKinney, R.19
Ng, A.20
Nieves, J.21
O'Keefe, R.22
Papapoulos, S.23
Sen, H.T.24
Van Der Meulen, M.C.H.25
Weinstein, R.S.26
Whyte, M.27
more..
-
41
-
-
77951634320
-
Long-term use of bisphosphonates in osteoporosis
-
Watts, N. B., and Diab, D. L. (2010) Long-term use of bisphosphonates in osteoporosis. J. Clin. Endocrinol. Metab. 95, 1555-1565
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 1555-1565
-
-
Watts, N.B.1
Diab, D.L.2
-
42
-
-
60849086230
-
Diagnosis and treatment of osteoporosis
-
Sweet, M. G., Sweet, J. M., Jeremiah, M. P., and Galazka, S. S. (2009) Diagnosis and treatment of osteoporosis. Am. Fam. Physician 79, 193-200
-
(2009)
Am. Fam. Physician
, vol.79
, pp. 193-200
-
-
Sweet, M.G.1
Sweet, J.M.2
Jeremiah, M.P.3
Galazka, S.S.4
|